Related Experiment Video
Updated: May 27, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
MLC tracking for Elekta VMAT: a modelling study.
G A Davies1, G Poludniowski, S Webb
1Joint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK. gemma.davies@icr.ac.uk
Physics in Medicine and Biology
|November 15, 2011
Summary
Dynamic multileaf collimator (dMLC) tracking improves volumetric modulated arc therapy (VMAT) accuracy for lung cancer patients. Faster leaf speeds and closer control point spacing enhance VMAT motion compensation, offering a less invasive alternative to breath-hold techniques.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Technology
Background:
- Volumetric Modulated Arc Therapy (VMAT) is an advanced radiotherapy technique.
- Motion during treatment delivery, particularly in lung cancer, can compromise dose accuracy.
- Current motion compensation techniques like breath-hold can reduce treatment efficiency and patient comfort.
Purpose of the Study:
- To develop and validate a model for simulating VMAT delivery on Elekta systems.
- To investigate the efficacy of dynamic multileaf collimator (dMLC) tracking for VMAT motion compensation in lung cancer.
- To evaluate the impact of various parameters on dMLC tracking performance and treatment time.
Main Methods:
- Development and experimental validation of a VMAT delivery simulation model for Elekta control systems.
- Application of the model to VMAT lung treatment plans with dMLC tracking for five patients.
- Analysis of treatment time increases for different 1D rigid-body motion trajectories.
- Evaluation of control point spacing, MLC leaf speed, and dose levels on dMLC tracking delivery time.
Main Results:
- dMLC tracking accuracy increases with decreased control point spacing.
- Faster MLC leaf speed is beneficial for motion trajectories with shorter periods and larger amplitudes.
- Treatment time increases with dMLC tracking were quantified for various motion patterns.
- dMLC tracking performance is dependent on the amplitude and time period of target motion.
Conclusions:
- dMLC tracking is a promising technology for VMAT motion compensation in lung cancer radiotherapy.
- It offers advantages over breath-hold techniques by maintaining higher treatment efficiency and being less invasive.
- Optimizing parameters like leaf speed and control point spacing is crucial for effective dMLC tracking.
